NCT05680675 2025-02-06Dual-Tracer Theranostic PETUniversity of UtahPhase NA Completed50 enrolled 8 charts
NCT01794793 2024-10-01Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored StudiesRECORDATI GROUPPhase 4 Completed337 enrolled 8 charts
NCT01218555 2022-01-27Study of Everolimus (RAD001) in Combination With LenalidomideEmory UniversityPhase 1 Completed44 enrolled 9 charts
NCT01115803 2019-02-05A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid TumorsEli Lilly and CompanyPhase 1 Terminated29 enrolled 19 charts
NCT00753415 2015-03-17A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)Merck Sharp & Dohme LLCPhase 1 Completed37 enrolled 10 charts